Vertex Pharmaceuticals target price raised to $650 from $550
VRTX•Wells Fargo raised its target price for Vertex Pharmaceuticals to $650 from $550.
Related News
Marzetti Q1 sales slightly miss, profit falls on cyclospora outbreak, higher costs
MZTI•
Brazil economists raise inflation, rate forecasts after Lula reelection
TLT•
Shopify Q3 revenue rises 32%, GMV hits $119 bln
SHOP•
Onsemi: Rosenblatt Securities cuts target price to $80 from $85
ON•
Nano Nuclear Energy Inc.: Wedbush initiates coverage with outperform rating; price target $18
NNE•